PRECISION BIOSCIENCES INC (DTIL) › Shareholders' EquityPRECISION BIOSCIENCES INC (DTIL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$26.37M2018: $39.96M2019: $138.31M2020: $44.42M2021: $91.17M2022: $60.43M2023: $18.86M2024: $56.39M2025: $92.25M$92.25M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$92.25M+63.6%2024$56.39M+199.0%2023$18.86M-68.8%2022$60.43M-33.7%2021$91.17M+105.2%2020$44.42M-67.9%2019$138.31M+246.1%2018$39.96M+251.5%2017-$26.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share